INTELLICELL™ BIOSCIENCES
IntelliCell BioSciences, Inc. operates as a regenerative medicine company. Its proprietary patent pending process involves the application of ultrasonic cavitation (sound waves) to the extracted adipose tissue for the separation of adult autologous vascular cells (AAVC’s) from the blood vessels in adult adipose (fat) tissue. These AAVC’s or stromal vascular fraction are a heterogeneous mixture of regenerative cells and autologous adult stem cells that promote the healing of injured tissue. A... AVC’s contain adult stem cells, fibroblasts, growth factors, and other cellular components. The company plans to focus on regenerative medicine in the areas of aesthetics, orthopedics, sports medicine, pain management, and periodontal diseases. IntelliCell BioSciences, Inc. also licenses its technologies in Canada, Australia, New Zealand, Thailand, and the United States. The company is based in New York, New York.
INTELLICELL™ BIOSCIENCES
Industry:
Biotechnology Life Science Medical
Founded:
1999-01-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.intellicellbiosciences.com
Total Employee:
11+
Status:
Active
Contact:
12122493050
Email Addresses:
[email protected]
Total Funding:
3.19 M USD
Technology used in webpage:
Joker Thomson Reuters Multimedia Center
Founder
Stock Details
Official Site Inspections
http://www.intellicellbiosciences.com Semrush global rank: 7.73 M Semrush visits lastest month: 437
- Host name: 64.190.63.222
- IP address: 64.190.63.222
- Location: Cleveland United States
- Latitude: 41.5043
- Longitude: -81.6786
- Metro Code: 510
- Timezone: America/New_York
- Postal: 44114
More informations about "IntelliCell™ BioSciences"
IntelliCell™ BioSciences - Crunchbase Company Profile …
IntelliCell BioSciences, Inc. operates as a regenerative medicine company. Its proprietary patent pending process involves the application of ultrasonic …See details»
Intellicell Biosciences, Inc. Company Profile | New York, NY ...
Find company research, competitor information, contact details & financial data for Intellicell Biosciences, Inc. of New York, NY. Get the latest business insights from Dun & Bradstreet.See details»
Intellicell Biosciences - LinkedIn
Intellicell Biosciences | 285 followers on LinkedIn. IntelliCell™ is pioneering a new proprietary medical process that results in acquiring Vascular Fraction Cells (VFC). VFC is also known as ...See details»
Intellicell BioSciences - Company Profile - Tracxn
Feb 24, 2025 Website: intellicellbiosciences.com; Social: Key Metrics. Latest Funding Round. Post IPO, Nov 30, 2012, $375K. Ranked. 33 rd among 63 active competitors. Similar …See details»
Investor Relations OTCQB: SVFC - Intellicell Biosciences
Jan 9, 2012 Webcasts: Corporate Presentation Webcast, January 9, 2012 at 11:30 a.m. (PT) Intellicell® Biosciences Ticker Symbol for Stocks: OTCQB: SVFC. For Investor Relations …See details»
Intellicell Biosciences - Craft
IntelliCell BioSciences is a regenerative medicine company. Its proprietary patent pending process involves the application of ultrasonic cavitation (sound waves) to the extracted …See details»
Intellicell Biosciences, Inc. - Drug pipelines, Patents, Clinical ...
Explore Intellicell Biosciences, Inc. with its drug pipeline, therapeutic area, technology platform, 5 news, Drug:Autologous stromal vascular cell therapy (Invigorcell).See details»
Intellicell Biosciences - Company Profile - BizStanding
Company Profile. Industry: Biotechnology Site: intellicellbiosciences.com Description: IntelliCell™ is pioneering a new proprietary medical process that results in acquiring Vascular Fraction …See details»
Intellicell Biosciences, Inc. in New York, NY - (646) 576-8700
Intellicell Biosciences, Inc. is in the Medical Laboratories business. View competitors, revenue, employees, website and phone number.See details»
Company Intellicell Biosciences Inc - MarketScreener.com
Jun 2, 2011 Intellicell Biosciences Inc: Company profile, business summary, shareholders, managers, financial ratings, industry, sector and market information | Other OTC ...See details»
Intellicell Biosciences, Inc.:Company Profile & Technical Research ...
Discovery Company profile page for Intellicell Biosciences, Inc. including technical research,competitor monitor,market trends,company profile& stock symbolSee details»
Intellicell Biosciences Overview | SignalHire Company Profile
Organization Website: intellicellbiosciences.com : Social Links: Phone Number: 12122493050: Intellicell Biosciences industries Biotech: Intellicell Biosciences Employees Size 1-10 …See details»
IntelliCell BioSciences - VentureRadar
IntelliCell BioSciences VentureRadar profile. Find out more about IntelliCell BioSciences, Regenerative Medicine.See details»
IntelliCell BioSciences - Company Profile & Staff Directory
IntelliCell™ is pioneering a new proprietary medical process that results in acquiring Vascular Fraction Cells (VFC). VFC is also known as stromal vascular fraction. VFC cells are known to …See details»
IntelliCell™ BioSciences - Golden
A company developing regenerative medicine for age related diseases. Overview Structured Data Issues Contributors Activity. ContentsSee details»
Overview, Competitors, And Employees - Ampliz.com
Website: www.intellicellbiosciences.com. Founded: NA. Employees: 0-10 Stock Exchange: NA . Regenerative Medicine Biotechnology Pharmaceuticals . About Intellicell Biosciences . …See details»
Company Intellicell Biosciences Inc OTC Bulletin Board
Intellicell Biosciences Inc: Company profile, business summary, shareholders, managers, financial ratings, industry, sector and market information | OTC Bulletin ...See details»
IntelliCell BioSciences - Products, Competitors, Financials, …
IntelliCell BioSciences has developed proprietary technologies that allow for the efficient and reproducible separation of stromal vascular fraction containing adipose adult stem cells that …See details»
Intellicell Biosciences announces the licensing of its proprietary ...
Jan 10, 2012 The Company licensed the technology for Australia & New Zealand for a one-time payment offer $700,000 and 12 1/2% Royalty Stream NEW YORK--(BUSINESS WIRE)-- …See details»
World's first "Synthetic Biological Intelligence" runs on living …
Mar 3, 2025 The world's first "biological computer" that fuses human brain cells with silicon hardware to form fluid neural networks has been commercially launched, ushering in a new …See details»